AirSculpt Technologies, Inc. (AIRS) vs Health Catalyst, Inc. (HCAT)

A side-by-side comparison of AirSculpt Technologies, Inc. and Health Catalyst, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AIRS vs HCAT

growth of $100 · dividends reinvested · last 5y
AIRS -87.4% (-34.0%/yr)HCAT -96.7% (-49.3%/yr)AIRS compounded faster over this window
050100Start $10020222023202420252026$13$3
AIRS HCAT

AIRS vs HCAT: by the numbers

  • •AIRS is the larger company ($134M vs $133M market cap).
  • •Both run net losses; AIRS's is the smaller (-7.79% vs -90.61% net margin).
  • •AIRS grew revenue faster over the past five years (8.17% vs 6.24% CAGR).

Metrics side by side

Valuation

MetricAIRSHCAT
P/S ratio0.890.45
P/B ratio1.281.32
EV / EBITDA436.0774.95
FCF yield0.57%9.85%

Profitability

MetricAIRSHCAT
Gross margin57.63%33.47%
Operating margin-7.85%-11.60%
Net margin-7.79%-90.61%
ROE-11.20%-262.64%
ROIC-7.01%-21.42%

Growth (annualized)

MetricAIRSHCAT
Revenue CAGR (5Y)8.17%6.24%
FCF CAGR (5Y)-52.36%N/A
Total return CAGR (5Y)N/A-48.35%

Frequently asked

Which has grown faster, AIRS or HCAT?
Over the past five years, AIRS grew revenue faster — AIRS at a 8.17% CAGR versus HCAT at 6.24%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.